Literature DB >> 23911199

MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny.

Rachael Nimmo1, Aldo Ciau-Uitz, Cristina Ruiz-Herguido, Shamit Soneji, Anna Bigas, Roger Patient, Tariq Enver.   

Abstract

Hematopoietic stem cells (HSCs) emerge during embryogenesis from hemogenic endothelium, but it remains unclear how the HSC lineage is initially established from mesoderm during ontogeny. In Xenopus, the definitive hemangioblast precursors of the HSC lineage have been identified in dorsal lateral plate (DLP) mesoderm, and a transcriptional gene regulatory network (GRN) controlling hemangioblast programming has been elucidated. Herein, we identify an essential role for microRNAs (miRNAs) in establishing the mesodermal lineage leading to both HSC emergence and vasculogenesis and determine that a single miRNA, miR-142-3p, is primarily responsible for initiation of definitive hemangioblast specification. miR-142-3p forms a double-negative gate unlocking entry into the hemangioblast program, in part by inhibiting TGFβ signaling. Our results table miR-142-3p as a master regulator of HSC lineage specification, sitting at the apex of the hierarchy programming the adult hemangioblast, thus illustrating that miRNAs can act as instructive determinants of cell fate during development.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911199     DOI: 10.1016/j.devcel.2013.06.023

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  42 in total

Review 1.  Progress towards generation of human haematopoietic stem cells.

Authors:  Lara Wahlster; George Q Daley
Journal:  Nat Cell Biol       Date:  2016-10-10       Impact factor: 28.824

Review 2.  Novel roles for Sm-class RNAs in the regulation of gene expression.

Authors:  Demián Cazalla
Journal:  RNA Biol       Date:  2018-07-09       Impact factor: 4.652

Review 3.  Virus meets host microRNA: the destroyer, the booster, the hijacker.

Authors:  Yang Eric Guo; Joan A Steitz
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

4.  miR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development.

Authors:  Gianni Carraro; Amit Shrestha; Jana Rostkovius; Adriana Contreras; Cho-Ming Chao; Elie El Agha; Breanne Mackenzie; Salma Dilai; Diego Guidolin; Makoto Mark Taketo; Andreas Günther; Maya E Kumar; Werner Seeger; Stijn De Langhe; Guillermo Barreto; Saverio Bellusci
Journal:  Development       Date:  2014-02-19       Impact factor: 6.868

5.  MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma.

Authors:  Chang'e Jin; Liang Xiao; Zeqiang Zhou; Yan Zhu; Geng Tian; Shuhua Ren
Journal:  Hum Cell       Date:  2019-06-05       Impact factor: 4.174

6.  Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.

Authors:  Colin L Sweeney; Ruifeng Teng; Hongmei Wang; Randall K Merling; Janet Lee; Uimook Choi; Sherry Koontz; Daniel G Wright; Harry L Malech
Journal:  Stem Cells       Date:  2016-02-29       Impact factor: 6.277

7.  Dissecting BMP signaling input into the gene regulatory networks driving specification of the blood stem cell lineage.

Authors:  Arif Kirmizitas; Stuart Meiklejohn; Aldo Ciau-Uitz; Rachel Stephenson; Roger Patient
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-06       Impact factor: 11.205

8.  RNA polymerase II pausing modulates hematopoietic stem cell emergence in zebrafish.

Authors:  Qiwen Yang; Xiuli Liu; Ting Zhou; Jennifer Cook; Kim Nguyen; Xiaoying Bai
Journal:  Blood       Date:  2016-08-12       Impact factor: 22.113

9.  MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis.

Authors:  Christine Roden; Jun Lu
Journal:  Curr Stem Cell Rep       Date:  2016-07-01

10.  miR-142-3p inhibits cancer cell proliferation by targeting CDC25C.

Authors:  Xu-Chen Cao; Yue Yu; Li-Kun Hou; Xiao-Hu Sun; Jie Ge; Bin Zhang; Xin Wang
Journal:  Cell Prolif       Date:  2016-01-25       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.